Venn Life Sciences Holdings Plc (VENN):製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Venn Life Sciences Holdings Plc (VENN) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C8241
◆発行会社(調査会社):GlobalData
◆発行日:2018年10月
◆ページ数:46
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:イギリス
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Venn Life Sciences Holdings Plc (Venn Life Sciences), formerly Armscote Investment Company Plc is a contract research organization that offers drug development, clinical trial management and resourcing solutions. The organization offers drug development services such as clinical pharmacology, drug candidate selection, in-licensing and technical due diligence, non-clinical and pre-clinical development, regulatory affairs and consulting, pharmacometrics and PK and PD modelling, pharmaceutical development, and others. It offers clinical services including feasibility, regulatory affairs, project management, clinical monitoring, biometrics, interactive response technology, resourcing and recruitment, legal services and investigator initiated studies. Venn Life Sciences caters to pharmaceutical, biotechnology and medical device companies and academic organizations. It has operations in the UK, France, the Netherlands, Germany and Ireland. Venn Life Sciences is headquartered in London, the UK.

Venn Life Sciences Holdings Plc (VENN) – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
Venn Life Sciences Holdings Plc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Venn Life Sciences Holdings Plc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7
Venn Life Sciences Holdings Plc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Venn Life Sciences Holdings Plc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9
Venn Life Sciences Holdings Plc, Medical Devices Deals, 2012 to YTD 2018 10
Venn Life Sciences Holdings Plc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11
Venn Life Sciences Holdings Plc, Pharmaceuticals & Healthcare, Deal Details 12
Venture Financing 12
InnoVenn Raises USD1 Million in Venture Financing Round 12
Venn Life Sciences Raises US$4 Million In Venture Financing 13
Partnerships 14
Venn Life Sciences Enters into Partnership with European Biotechnology Company 14
Venn Life Sciences Forms Joint Venture With Cellulac And Biopharmed West 15
Venn Life Sciences Forms Joint Venture In Russia 16
Merger 17
Venn Life Sciences And Encorium Announce Merger 17
Equity Offering 18
Venn Life Sciences Raises USD0.9 Million in Private Placement of Shares 18
Venn Life Sciences to Raise USD5.5 Million in Private Placement of Shares 19
Venn Life Sciences Raises USD3.1 Million in Private Placement of Shares 20
Venn Life Sciences Raises USD1.7 Million in Private Placement of Shares 21
Venn Life Sciences Completes IPO For US$4 Million 22
Acquisition 24
Venn Life Sciences Holdings to Acquire Remaining 11.03% Stake in Venn Life Sciences France 24
Integumen to Acquire Innovenn UK from Venn Life Sciences and Helium Rising Stars Fund for USD6 Million 25
Venn Life Sciences Acquires Kinesis Pharma 26
Venn Life Sciences Acquires Majority Stake in Cardinal Systems 27
Venn Life Sciences Acquires Labskin, SYN1113 And Related Equipment From Evocutis For US$0.35 Million 28
Venn Life Sciences Acquires Medevol, Clinical Research Organization, For US$1 Million 29
Venn Life Sciences To Acquire Majority Stake In CRM Clinical Trials For US$0.8 Million 30
Armscote Investment Company Acquires Venn Life Sciences In Reverse Take-Over Transaction For US$4.63 Million 31
Venn Life Sciences Holdings Plc – Key Competitors 32
Venn Life Sciences Holdings Plc – Key Employees 33
Venn Life Sciences Holdings Plc – Locations And Subsidiaries 34
Head Office 34
Other Locations & Subsidiaries 34
Recent Developments 36
Financial Announcements 36
Sep 25, 2018: Venn Life Sciences Holdings: Interim Results for 6 months ended 30 June 2018 36
May 17, 2018: Venn Life Sciences Holdings: Preliminary Final Results for the year ended 31 December 2017 38
Sep 12, 2017: Venn Life Sciences Holdings Announces Half-year Report Interim Results for 6 months ended 30 June 2017 39
Jul 20, 2017: Venn Life Sciences Holdings Announces Half year end update 41
Mar 22, 2017: Venn Life Sciences Holdings Announces Final Results for the year ended 31 December 2016 42
Corporate Communications 43
Mar 21, 2018: Venn Life Sciences Holdings Announces Resignation of Director 43
Jul 25, 2017: Venn Life Sciences: Senior Management Appointment 44
Jul 25, 2017: Venn Life Sciences Holdings Announces Senior Management Appointment 45
Appendix 46
Methodology 46
About GlobalData 46
Contact Us 46
Disclaimer 46

List of Tables
Venn Life Sciences Holdings Plc, Pharmaceuticals & Healthcare, Key Facts, 2017 2
Venn Life Sciences Holdings Plc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Venn Life Sciences Holdings Plc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7
Venn Life Sciences Holdings Plc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Venn Life Sciences Holdings Plc, Deals By Therapy Area, 2012 to YTD 2018 9
Venn Life Sciences Holdings Plc, Medical Devices Deals, 2012 to YTD 2018 10
Venn Life Sciences Holdings Plc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11
InnoVenn Raises USD1 Million in Venture Financing Round 12
Venn Life Sciences Raises US$4 Million In Venture Financing 13
Venn Life Sciences Enters into Partnership with European Biotechnology Company 14
Venn Life Sciences Forms Joint Venture With Cellulac And Biopharmed West 15
Venn Life Sciences Forms Joint Venture In Russia 16
Venn Life Sciences And Encorium Announce Merger 17
Venn Life Sciences Raises USD0.9 Million in Private Placement of Shares 18
Venn Life Sciences to Raise USD5.5 Million in Private Placement of Shares 19
Venn Life Sciences Raises USD3.1 Million in Private Placement of Shares 20
Venn Life Sciences Raises USD1.7 Million in Private Placement of Shares 21
Venn Life Sciences Completes IPO For US$4 Million 22
Venn Life Sciences Holdings to Acquire Remaining 11.03% Stake in Venn Life Sciences France 24
Integumen to Acquire Innovenn UK from Venn Life Sciences and Helium Rising Stars Fund for USD6 Million 25
Venn Life Sciences Acquires Kinesis Pharma 26
Venn Life Sciences Acquires Majority Stake in Cardinal Systems 27
Venn Life Sciences Acquires Labskin, SYN1113 And Related Equipment From Evocutis For US$0.35 Million 28
Venn Life Sciences Acquires Medevol, Clinical Research Organization, For US$1 Million 29
Venn Life Sciences To Acquire Majority Stake In CRM Clinical Trials For US$0.8 Million 30
Armscote Investment Company Acquires Venn Life Sciences In Reverse Take-Over Transaction For US$4.63 Million 31
Venn Life Sciences Holdings Plc, Key Competitors 32
Venn Life Sciences Holdings Plc, Key Employees 33
Venn Life Sciences Holdings Plc, Other Locations 34
Venn Life Sciences Holdings Plc, Subsidiaries 34

List of Figures
Venn Life Sciences Holdings Plc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Venn Life Sciences Holdings Plc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Venn Life Sciences Holdings Plc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Venn Life Sciences Holdings Plc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Venn Life Sciences Holdings Plc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Venn Life Sciences Holdings Plc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 7
Venn Life Sciences Holdings Plc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Venn Life Sciences Holdings Plc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9
Venn Life Sciences Holdings Plc, Medical Devices Deals, 2012 to YTD 2018 10

★海外企業調査レポート[Venn Life Sciences Holdings Plc (VENN):製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Houlihan Lokey Inc (HLI):企業の財務・戦略的SWOT分析
    Summary Houlihan Lokey Inc (Houlihan) is an investment bank. It provides corporate finance, financial advisory, financial restructuring and strategic consulting services. The bank’s corporate finance services include mergers and acquisitions, capital markets, private fund advisory and board advisory …
  • Pakistan Petroleum Limited (PPL)-石油・ガス分野:企業M&A・提携分析
    Summary Pakistan Petroleum Limited (PPL) is an upstream oil and gas company. It explores, develops and produces crude oil and natural gas resources. The company produces crude oil, natural gas, natural gas liquids, liquefied petroleum gas and barytes. It operates producing fields in Sui, Kandhkot, A …
  • Bandera Electric Cooperative, Inc.:発電所・企業SWOT分析
    Bandera Electric Cooperative, Inc. – Power Plants and SWOT Analysis, 2017 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information o …
  • Neo Performance Materials Inc:企業の戦略・SWOT・財務分析
    Neo Performance Materials Inc - Strategy, SWOT and Corporate Finance Report Summary Neo Performance Materials Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …
  • OGK-2 (OGKB):企業の財務・戦略的SWOT分析
    OGK-2 (OGKB) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the pote …
  • United Technologies Corp (UTX):企業の財務・戦略的SWOT分析
    United Technologies Corp (UTX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakn …
  • GeoVax Labs Inc (GOVX)-製薬・医療分野:企業M&A・提携分析
    Summary GeoVax Labs Inc (GeoVax) is a clinical-stage biotechnology company, which develops human vaccines for diseases caused by HIV, cancer and other infectious diseases using Modified Vaccinia Ankara Virus-Like Particle (MVA-VLP) vaccine platform. The company’s vaccine development programs focus o …
  • China Gezhouba Group Co Ltd (600068):電力:M&Aディール及び事業提携情報
    Summary China Gezhouba Group Co Ltd (CGGC) is an engineering, procurement and construction (EPC) company. It provides a wide range of services including dredging, foundation works, building construction, engineering survey, designing, construction management and consultancy, and relevant technology …
  • SOCO International plc (SIA):企業の財務・戦略的SWOT分析
    Summary SOCO International Plc (SOCO) is an oil and gas company that explores, discovers and produces oil and gas reserves. The company offers appraisal and field development services. It provides training and skills and support local communities. SOCO produces and supplies natural resources. SOCO h …
  • Seikagaku Corp (4548):製薬・医療:M&Aディール及び事業提携情報
    Summary Seikagaku Corp (Seikagaku) is a manufacturer and supplier of pharmaceuticals and medical devices. The company offers products such as pharmaceuticals and medical devices, bulk products, endotoxin-detecting reagents and oral care products. It manufactures and markets pharmaceutical products c …
  • Sunoco LP (SUN):石油・ガス:M&Aディール及び事業提携情報
    Summary Sunoco LP (Sunoco), a master limited partnership company that sells motor fuels in retail and wholesale channels. It offers motor fuel under brands such as Sunoco, Citgo, Chevron, Conoco, Aloha, Exxon, Mahalo, Mobil, Phillips 66, Texaco, Shell, Shamrock and Valero. The company operates throu …
  • Huneed Technologies
    Huneed Technologies - Strategy, SWOT and Corporate Finance Report Summary Huneed Technologies - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Denver Water:企業の戦略的SWOT分析
    Denver Water - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. …
  • ImmunoCellular Therapeutics Ltd (IMUC)-医療機器分野:企業M&A・提携分析
    Summary ImmunoCellular Therapeutics Ltd (IMCU) is a clinical-stage biotechnology company which develops immune-based therapies for the treatment of various cancers. The product pipeline of the company includes active immunotherapies and patented monoclonal antibodies. IMCU’s immunotherapies product …
  • SATCO Products Inc:企業の戦略的SWOT分析
    SATCO Products Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and ser …
  • Tech Mahindra Limited (TECHM):企業の財務・戦略的SWOT分析
    Tech Mahindra Limited (TECHM) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …
  • Petrobras Argentina SA:石油・ガス:M&Aディール及び事業提携情報
    Summary Petrobras Argentina SA (PESA), a subsidiary of Pampa Energia S.A, is an integrated energy company. It carries out the exploration and production of crude oil and natural gas, refining of crude oil, transportation, and marketing of oil and refined products. The company’s product portfolio inc …
  • BioSilta Ltd-製薬・医療分野:企業M&A・提携分析
    Summary BioSilta Ltd (Biosilta) is a biotechnology company that develops and markets reagent based microbial growth systems and accessories. The company offers products, which include enpresso growth systems, flasks, plates and seals. Its enpresso growth systems are used in the production of recombi …
  • TxCell SA (TXCL):企業の財務・戦略的SWOT分析
    Summary Txcell SA (Txcell) a subsidiary of Sangamo Therapeutics Inc, is a biotechnology company that develops personalized cellular immunotherapies using regulatory T cells (Treg) for the treatment of autoimmune and inflammatory diseases as well as transplantation-related inflammatory disorders. The …
  • University of British Columbia-製薬・医療分野:企業M&A・提携分析
    Summary University of British Columbia (UBC) is a research institute that offers educational services. The university provides undergraduate, graduate educational programs, and research programs through its schools and faculties. It provides cultural, recreational and social activities for its stude …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆